Pasithea Therapeutics Corp Financial Overview
Pasithea Therapeutics Corp's market cap is currently $26.43M. The company's EPS TTM is $-12.686; its P/E ratio is -0.23; Pasithea Therapeutics Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.